Integrative identification of non-coding regulatory regions driving metastatic prostate cancer
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Brian J Woo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA; Department of Urology, University of Califo…. Hauptthemen laut MEDLINE: RNA Splicing Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Large-scale sequencing efforts have been undertaken to understand the mutational landscape of the coding genome. However, the vast majority of variants occur within non-coding genomic regions. We designed an integrative computational and experimental framework to identify recurrently mutated non-coding regulatory regions that drive tumor progression. Applying this framework to sequencing data from a large prostate cancer patient cohort revealed a large set of candidate drivers. We used (1) in silico analyses, (2) massively parallel reporter assays, and (3) in vivo CRISPR interference screens to systematically validate metastatic castration-resistant prostate cancer (mCRPC) drivers. One identified enhancer region, GH22I030351, acts on a bidirectional promoter to simultaneously modulate expression of the U2-associated splicing factor SF3A1 and chromosomal protein CCDC157. SF3A1 and CCDC157 promote tumor growth in vivo. We nominated a number of transcription factors, notably SOX6, to regulate expression of SF3A1 and CCDC157. Our integrative approach enables the systematic detection of non-coding regulatory regions that drive human cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA; Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Compr…
- Vector Institute, Toronto, ON, Canada; Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.
- Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Department of Rad…
Förderung
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- NCI
Zitieren
APA
Woo, B. J., Moussavi-Baygi, R., Karner, H., Karimzadeh, M., Yousefi, H., Lee, S., Garcia, K., Joshi, T., Yin, K., Navickas, A., Gilbert, L. A., Wang, B., Asgharian, H., Feng, F. Y., & Goodarzi, H. (2024). Integrative identification of non-coding regulatory regions driving metastatic prostate cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114764
Vancouver
Woo BJ, Moussavi-Baygi R, Karner H, Karimzadeh M, Yousefi H, Lee S, et al. Integrative identification of non-coding regulatory regions driving metastatic prostate cancer. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114764
BibTeX
@article{Woo2024,
author = {Woo, Brian J and Moussavi-Baygi, Ruhollah and Karner, Heather and Karimzadeh, Mehran and Yousefi, Hassan and Lee, Sean and Garcia, Kristle and Joshi, Tanvi and Yin, Keyi and Navickas, Albertas and Gilbert, Luke A and Wang, Bo and Asgharian, Hosseinali and Feng, Felix Y and Goodarzi, Hani},
title = {Integrative identification of non-coding regulatory regions driving metastatic prostate cancer},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114764}
}
EUVIMED